Ask where CIL001 tinnitus study updates will be published
Send a short enquiry to clinicalinfo@cilcare.com, the clinical-studies contact on Cilcare's official page, asking where public updates about the upcoming CIL001 tinnitus study will be published. You send it yourself, from your own email. Do not include personal details, tinnitus history or any medical information.
- Now — About 5 minutes
- Afterwards — A reply is possible
- The need
- Cilcare describes an upcoming interventional CIL001 study focused on cochlear synaptopathy in people with tinnitus, aiming to investigate restoration of auditory synapse connections. Where its public updates will appear is not yet clear.
- Afterwards
- Upcoming, not current enrolment. The official page describes CIL001 as administered through a single intratympanic injection, but the complete future participation burden is not yet stated. Any future screening or study commitment is separate.
Goes to the Cilcare clinical studies team at clinicalinfo@cilcare.com. Nothing is sent from here — you send it yourself.
Action Copilot
The Copilot may only use facts Tinnitus Action has approved for this action. It cannot add statistics, claims or anything about health.
Uses a written template. No AI.
What you should know
This is an information enquiry only. Contacting Cilcare does not register you, does not establish eligibility and is not enrolment. Tinnitus Action is not affiliated with Cilcare.
How this is counted
A draft or opened destination is not counted. The action is added to progress only when you tell us you sent, submitted, gave or completed it.
Action counts are self-reported. They show coordinated activity, not independently verified impact.
For this action, that moment is: You tell us you sent it.